On our path to accelerated approval….
We patiently await canine study to back up our 2x phase2b trials knowing the objective data from our SAS, NFL and all other content we and others have generated on this amazing molecule is consistent, safe and fills an unmet need.
Keep turning the screws on the FDA. Eventually they will approve our molecule for use across the globe.
On our path to accelerated approval….We patiently await canine...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.010(2.44%) |
Mkt cap ! $166.9M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 42.0¢ | 40.0¢ | $168.2K | 411.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3500 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 50665 | 2 |
View Market Depth
| Last trade - 16.11pm 18/07/2025 (20 minute delay) ? |
| PAR (ASX) Chart |